The Pharmaceutical Market: Denmark

Publisher Name :
Date: 25-Apr-2013
No. of pages:
Inquire Before Buying

OVERVIEW OF THE PHARMACEUTICAL MARKET IN DENMARK

The macroenvironment for the Danish pharmaceutical industry is improving. The centre-left coalition, of the Social Democratic Party, the Socialist People’s Party and the Social Liberal Party, took office in October 2011. Denmark suffered a deep recession and economic recovery is stalling with negative GDP growth projected for 2012. Denmark has an ageing population, and the Economist Intelligence Unit projects that the population aged 65 and over will constitute more than one-fifth of the total population by 2016. As a result, healthcare is increasingly focused on preventative care and there will be a continuing demand for new therapies so that patients can be treated more effectively.

The increasing pharmaceutical expenditure in Denmark has led to price freezes and caps in recent years. A price ceiling, which has fixed pharmaceutical prices at the level they were five years ago, was extended to remain in place until the end of 2011. This extension is a sign of the government’s determination to keep the price of pharmaceuticals down, and so this form of price restriction is likely to continue beyond 2011. However, despite the positive results from cost-containment measures, efforts to reduce the cost of pharmaceuticals have proved unsuccessful. The savings made have been more than counterbalanced by the wider use of new and expensive pharmaceuticals, which are required to ensure the most effective treatment. This is especially true in areas such as hypertension, high cholesterol and so on, where many new therapies have become available recently.

Denmark has strong domestic production, but many producers focus on the export market. Due to the presence of Novo Nordisk, Denmark is a major global supplier of insulin in retail form. In August 2011, Novo Nordisk announced it is planning to build two new office buildings in Bagsværd. Previously, in June 2011, the company announced it is to invest in a new plant in Kalundborg, for the production of biopharmaceuticals.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales – for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

The Pharmaceutical Market: Denmark

Table Of Contents
N/A

  • Tire Roller Industry
    Tire roller is one of the most popular equipment used in the construction industry. A tire roller offers multiple services from building highways, industrial sites, binder courses, wear courses and many more. Tire rollers come with different features like easy adjustment of tyres, flexible ballast, oscillating tires, etc. that facilitates in doing a particular work. [...]
  • The Adhesive Paper Industry Looking At a Long Term Bonding
    Adhesives are used extensively in the Paper Industry. They are primarily two kinds ie, the adhesive is either water based or hot melts. The kind of requirement determines the adhesive type in this industry. Adhesives have a wide arena of application. It is used as envelope gums, bookbinding adhesives, for lamination of paper, corrugated adhesives, [...]
  • The Rising Horizon of Maintenance Market of Wind Turbines
    Wind turbines have been one of the most economical means of means of electric production. There are a number of benefits for operating wind turbines. It negates the risk of price factor arising out of dwindling fuel prices and also is independent of pollution and fuel imports. This method of electric production is a capital [...]
  • Liver Fibrosis Market
    Liver Fibrosis is a result of all chronic liver diseases. An extended illness from Liver Fibrosis leads to Cirrhosis of liver and finally liver cancer. It’s a serious disease and one of the world’s rising concern. The medical diagnosis of this disease is very painful and involves a risk of hazards such as severe bleeding [...]
  • Linzess Market All Set To Grow
    Linzess is a therapy for overcoming Irritable Bowel Syndrome with Constipation (IBS-C). The medicine is different and first of its kind that helps a person recover IBS-C. The medicine has some serious side effects so it is important that a person takes the medicine only if prescribed by the doctor. Some of the leading consumers [...]
  • The Oil Drilling Rig Industry
  • The Oil Drilling Rig Industry is characterized with a few typical work specific to this industry only. The work begins with the search for new oil basins or construction of wells. During this time the services of drilling contractors and …

  • HER2-Negative Breast Cancer’s Therapeutic Market
  • HER2-Negative Breast Cancer is the most common form of cancer occurring in women. The long term survival of patients diagnosed with HER2-Negative Breast Cancer depends solely on its early detection as till now there is no medicine that can cure …

  • The Market of Plate Heat Exchanger
  • Plate heat exchanger is not only very useful but its also easy to maintain, its compact design makes it more efficient, the product is highly cost-efficient and also the materials of this product are easily available. There are some limitations …

  • The Industry of Binding Machines
  • Binding of books and papers is one of the most important aspect of buying and selling books and thus the demand of binding machines. There are different kinds of binding machines available in the market. The binding type determines the …

  • The Boom In Women Infertility Market
  • Infertility is an abnormality in the regular functioning of the human reproductive system. Anyone of male or female might be suffering from this issue. Infertility in woman is caused by either a genetical factor or factors such as aging or …

  • Canada Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 112
    BMI View: Canada's epidemiological profile will continue to be attractive to manufacturers of medicines for non-communicable diseases. Despite the relatively rapid uptake of innovative pharmaceuticals, the burden of chronic conditions will increase over the next 15 years. Like many other developed states, Canada is introducing cost-containment measures to restrict the commercial opportunities presented to drugmakers. Headline Expenditure Projections ? Pharmaceuticals: CAD25.6bn (USD24.9bn)......
  • Estonia Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 104
    BMI View: Despite growing in recent years, the absolute value of the Estonian pharmaceutical market remains small and will continue to remain a marginal market in the Central and Eastern European region. Low-cost generic drugs are prevalent in the market, with doctors obliged to prescribe by international nonproprietary names (INNs), rather than branded names unless there is a specific medical reason for a branded product to be used. Despite the small size of the pharmaceuticals industry, it......
  • France Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 131
    BMI View: Despite the French government partially abandoning fiscal deficit targets in its 2015 budget, cost-containment measures will continue to weigh on the pharmaceuticals and healthcare sector for the foreseeable future. The government's strategy of emphasising preventive care and improved access to doctors will likely avoid long-term costs by reducing the burden or risks associated with unchecked conditions. Meanwhile, it will also sustain access to medicines, including prescription dr......
  • Iran Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 117
    BMI View: BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the sanction-induced currency crisis and high rates of inflation. The rapid depreciation of the rial means that we expect the value of the market to contract sharply in US dollar terms. While improved international relations have reduced the regulatory risk associated with operating in the market for multinational drugmakers, the recent proclamation of the Islamic State (IS) in neighbouring Iraq a......
  • Lebanon Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 116
    BMI View: The influx of Syrian refugees into Lebanon is putting a strain on the healthcare system, which is unable to meet the additional demand for treatment. Elevated political instability is putting the pharmaceutical sector at risk in terms of government policy relating to healthcare, while a poor economic outlook is detrimental to the ability to pay for medicine. We expect the continuation of the Syrian civil war to hamper growth in this market. Headline Expenditure Projections ? Phar......
  • Myanmar Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 64
    BMI View: Non-governmental organisations will continue to expand healthcare access in Myanmar - a boon for the country's pharmaceutical market. However, the country's poor protection of intellectual property, a weak healthcare system and political instability continues to pose high risks and will restrict company revenue streams. Headline Expenditure Projections ? Pharmaceutical sales: MMK324.8bn (USD350mn) in 2013 to MMK387.5bn (USD390mn) in 2014; +19.3% in local currency terms and +11.3%......
  • Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 121
    BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly as the government sees the sector as key to the diversification of the economy. The medical tourism industry in particular provides opportunities for both pharmaceutical and medical device companies. We expect multinational companies will continue to dominate the local market despite stringent regulatory laws. Headline Expenditure Projections ? Pharmaceuticals: SAR24.65bn (USD6.58bn) in 2013......
  • Sudan Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 59
    BMI View: The already depreciating Sudanese pound will come under further strain should oil prices continue their decline as oil exports account for around 70% of total exports in the country. We are already forecasting short-term negative growth in US dollar terms for the pharmaceutical market which could come under increased scrutiny should prices decline further. Our long-term outlook is more positive due to the government's plans to develop the pharmaceutical sector and expand access to ......
  • Switzerland Pharmaceuticals and Healthcare Report Q1 2015
    Published: 10-Dec-2014        Price: US $1295 Onwards        Pages: 106
    BMI View: The Swiss government will need to develop policies to maintain the country's long-term attractiveness as a site for clinical trials, especially as we expect cost of conducting clinical research to rise. The drivers of increased attractiveness of non-traditional locations for clinical studies include improving healthcare infrastructure, more and better trained medical professionals, and a growing requirement for local studies in the pharmaceutical approval process. We foresee a cont......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs